The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 82%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
CDT Environmental Technology Investment Holdings Ltd
CDTG · NASDAQ · USD · Market cap $3M
CDT Environmental Technology Investment Holdings Limited designs, develops, manufactures, sells, installs, operates, and maintains sewage treatment systems in China.
PASS · Titan Ethical · score 70.0Price as of 3 Nov 2026Daily close, not a live quote
Screened 2026-11-03 · the tape above runs as of 12:11 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price1.11 USD at the 3 Nov 2026 close
- Our regime readDistribution, as of 3 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- Last reviewed3 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-03).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
CDT Environmental Technology Investment Holdings Ltd holds its Distribution at $1.11. The statistical read favours the buyers, held for 19 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the buyers, held for 19 days |
| Price at the screen | $1.11 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | -2.03 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 6.89% | Below 33% | Interest-bearing debt is just 6.9% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 49.71% | Below 49% | Money owed to the company is 49.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
CDT Environmental Technology Investment clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 7%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CDTG's ethical verdict changes
Today CDTG passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
| EPS, trailing | -21.00 |
| Revenue growth | -36.1%revenue is shrinking |
| Profit margin | -55.9%currently unprofitable |
| Return on equity | -30.5%not currently earning a positive return on equity |
| FCF yield | -170.05% |
| Debt to equity | 0.20minimal debt: a conservative balance sheet |
| Current ratio | 1.46adequate liquidity, worth monitoring |
| Beta | -2.03barely tracks the market's swings |
| Short interest, float | 0.05% |
| 52-week range | 0.73 - 17.00 |
| Moat | NONE |
| Market cap | $3M |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to China and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCDTG trades on NASDAQ (the company is based in China). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 82%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 11.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 82%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 23.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 82%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 10.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 82%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 39.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 82%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 82%. Our forward projection puts the odds of a 10% gain over the next month near 21%.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- CDT Environmental Technology Announces Results of Extraordinary General Meeting Yahoo Finance · 28 Jul 2026
- CDT Environmental Technology Investment Holdings Regains Compliance with Nasdaq Minimum Bid Price Requirement Yahoo Finance · 7 Jul 2026
- CDT Environmental Technology Investment Holdings Limited to Hold Extraordinary General Meeting on July 28, 2026 Yahoo Finance · 6 Jul 2026
- Upcoming Stock Splits This Week (June 1 to June 5) – Stay Invested TipRanks · 1 Jun 2026
- Upcoming Stock Splits This Week (June 1 to June 5) – Stay Invested Yahoo Finance · 1 Jun 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $7.90 | -64.6% | · | $354 | -64.6% |
| 2 months | $10.00 | -72.0% | · | $280 | -72.0% |
| 3 months | $9.93 | -71.8% | · | $282 | -71.8% |
| 6 months | $10.75 | -74.0% | · | $261 | -74.0% |
| 1 year | $15.75 | -82.2% | · | $178 | -82.2% |
| 2 years | $99.75 | -97.2% | · | $28 | -97.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CDTG does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.